Antimicrobial Stewardship: What We All Just Need to Know

Magnus J Grabe; Fredrik Resman

doi:10.1016/j.euf.2018.06.012

Antimicrobial Stewardship: What We All Just Need to Know

Eur Urol Focus. 2019 Jan;5(1):46-49. doi: 10.1016/j.euf.2018.06.012. Epub 2018 Jun 30.

Authors

Magnus J Grabe¹, Fredrik Resman²

Affiliations

¹ Department of Translational Medicine, Division of Urological Cancer, Lund University, Malmö, Sweden. Electronic address: magnus.grabe@med.lu.se.
² Department of Translational Medicine, Clinical Infection Medicine, Lund University, Malmö, Sweden.

PMID: 29970303
DOI: 10.1016/j.euf.2018.06.012

Abstract

Context: Microbial resistance to antibiotics is increasing while antimicrobials are limited. Responsible use is necessary.

Objective: Describe the present acquisitions of antimicrobial stewardship programmes (ASPs) in general and in urology.

Evidence synthesis: Well-designed ASPs have an impact on reducing treatment duration, shortening intravenous treatment in favour of oral targeted therapy, and reducing the total antibiotic prescription. Moreover, the hospital length of stay can potentially be reduced without hazard for the patient.

Conclusions: It is recommended to set up an ASP for education and feedback as standard in urological practice. The exact design of the ASP should be tailored to regional prerequisites.

Keywords: Antimicrobial stewardship; Urinary tract infections; Urological surgery.

Publication types

Review

MeSH terms

Administration, Intravenous
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / therapeutic use
Antimicrobial Stewardship / methods*
Drug Resistance, Multiple, Bacterial
Hospitals
Humans
Length of Stay
Standard of Care
Time Factors
Urinary Tract Infections / drug therapy*
Urinary Tract Infections / microbiology

Substances

Anti-Bacterial Agents